Pfizer–BioNTech COVID-19 vaccine
The Expert Council on with the Ministry of Health advises against rushing the decision to have a booster dose of COVID-19 vaccines. The position of the expert council circulated by the Ministry of Health this morning after Health Minister Stoycho Katsarov yesterday said that a decision on a recommendation is pending at any moment from MA - the European Medicines Agency.
ulgaria has introduced new anti-COVID restrictions as the country battles a rapid surge of infections due to the Delta variant.
The eastern Balkan country has one of the highest coronavirus death rates in the European Union since the start of the pandemic.
Despite this, Bulgarian citizens are the most hesitant in the bloc to get vaccinated against COVID-19.
After former Prime Minister Boyko Borissov spoke about donating vaccines against COVID-19 in March and April, and the caretaker government continued talking in June decided on the donation in August, in September the procedure was completed by the Bulgarian institutions by a decision of the National Assembly on Wednesday (September 8).
The US Food and Drug Administration (FDA) has given its full approval to the use of the Pfizer / BioNTech vaccine in the United States. Although the vaccine has been given so far, this has only happened with an "emergency" authorization.
The two-dose vaccine has met "the high standard of safety, efficiency and quality of production," said acting FDA director Janet Woodstock.
A third dose of Pfizer Covid-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, according to findings published by the Health Ministry and cited by Reuters. The full details of the study were not released.
A new study out of the UK has shown that the effectiveness of the Pfizer/BioNTech vaccine is waning faster than others when up against a high viral load mutation of the coronavirus, like the Delta variant
As many as 12,996 vaccine doses from Pfizer, Moderna, AstraZeneca and Johnson&Johnson were administered in the last 24 hours, of which 9,316 represent the first dose, and 3,650 the second dose, according to a briefing released on Thursday by Romania's National COVID-19 Vaccination Coordination Committee (CNCAV).